Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Fortvita Biologics (USA)Inc clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our USA, China and Australia registers with Fortvita Biologics (USA)Inc as lead sponsor. Synced 10 Nov 2026
5Current trials
4Recruiting now
2Drugs in these trials
3Trial registers
At a glance

Fortvita Biologics (USA)Inc is the lead sponsor of 5 current clinical trials in our USA, China and Australia registers. 4 are recruiting patients now. The most common phase is Phase 1. The drugs named most often in its trials are IBI3003 and IBI3032. The most-studied condition is Healthy Volunteers (HV).

ClinicalTrials.gov trials by status

  • Recruiting480%
  • Not yet open120%

Trials by phase

  • Phase 1480%
  • Phase 1/2120%
01

Clinical trials sponsored by Fortvita Biologics (USA)Inc

5 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
A Study of IBI3032 in Healthy Participants
NCT07120425 · Healthy
Drug: IBI3032
Phase 1 Recruiting 2025-09 USA
IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
NCT06349408 · Locally Advanced Solid Tumor
Phase 1 Recruiting 2025-01 USA, China, Australia
Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors
NCT06963281 · Solid Tumors
Phase 1 Recruiting 2025-04 USA, China
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
NCT07336472 · Multiple Myeloma
Drug: IBI3003
Phase 1/2 Recruiting 2026-09 USA
A Study of IBI3042 in Healthy Adult Participants
NCT07842393 · Healthy Volunteers (HV)
Phase 1 Not yet open 2026-09 USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Fortvita Biologics (USA)Inc trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Fortvita Biologics (USA)Inc trials

5 conditions
04

By trial register

RegisterTrialsRecruiting
Clinical trials in USA54
Clinical trials in China22
Clinical trials in Australia11

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Healthy Volunteers (HV)

SponsorTrials
Hospital de Clinicas de Porto Alegre2
Jade Biosciences1
Eilean Therapeutics1

Sponsors with the most current trials registered for this condition.

06

Questions about Fortvita Biologics (USA)Inc trials

How many clinical trials does Fortvita Biologics (USA)Inc sponsor?

Fortvita Biologics (USA)Inc is the lead sponsor of 5 current trials on ClinicalTrials.gov in our USA, China and Australia registers, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.

Are Fortvita Biologics (USA)Inc trials recruiting?

Yes. 4 of its 5 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Fortvita Biologics (USA)Inc testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are IBI3003 (1) and IBI3032 (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.